These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31478151)

  • 21. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
    Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
    Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study.
    Kongsaengdao S; Arayawithchanont A; Samintharapanya K; Rojanapitayakorn P; Maneeton B; Maneeton N
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
    Factor SA; Molho ES; Evans S; Feustel PJ
    Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced Neck Muscle Strength and Altered Muscle Mechanical Properties in Cervical Dystonia Following Botulinum Neurotoxin Injections: A Prospective Study.
    Mustalampi S; Ylinen J; Korniloff K; Weir A; Häkkinen A
    J Mov Disord; 2016 Jan; 9(1):44-9. PubMed ID: 26828215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study).
    Tyślerowicz M; Dulski J; Gawryluk J; Sławek J
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
    Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
    J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
    Solish N; Carruthers J; Kaufman J; Rubio RG; Gross TM; Gallagher CJ
    Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haptic Feedback Manipulation During Botulinum Toxin Injection Therapy for Focal Hand Dystonia Patients: A Possible New Assistive Strategy.
    Atashzar SF; Shahbazi M; Ward C; Samotus O; Delrobaei M; Rahimi F; Lee J; Jackman M; Jog MS; Patel RV
    IEEE Trans Haptics; 2016; 9(4):523-535. PubMed ID: 27552765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey.
    Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; De Oliveira CQ; Verhagen AP
    J Neural Transm (Vienna); 2024 Jan; 131(1):43-51. PubMed ID: 37831150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia.
    Hok P; Hvizdošová L; Otruba P; Kaiserová M; Trnečková M; Tüdös Z; Hluštík P; Kaňovský P; Nevrlý M
    Sci Rep; 2021 Apr; 11(1):8322. PubMed ID: 33859210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
    Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia.
    Ferreira JJ; Colosimo C; Bhidayasiri R; Marti MJ; Maisonobe P; Om S
    Parkinsonism Relat Disord; 2015 Feb; 21(2):111-5. PubMed ID: 25499753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomy-guided injections of botulinum neurotoxin in neck muscles: how accurate is needle placement?
    Kreisler A; Simonin C; Degardin A; Mutez E; Defebvre L
    Eur J Neurol; 2020 Nov; 27(11):2142-2146. PubMed ID: 32579789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Ondo WG; Gollomp S; Galvez-Jimenez N
    Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.
    Comella CL; Jankovic J; Shannon KM; Tsui J; Swenson M; Leurgans S; Fan W;
    Neurology; 2005 Nov; 65(9):1423-9. PubMed ID: 16275831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.
    Schramm A; Bäumer T; Fietzek U; Heitmann S; Walter U; Jost WH
    J Neural Transm (Vienna); 2015 Oct; 122(10):1457-63. PubMed ID: 25547861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.
    Naumann M; Yakovleff A; Durif F;
    J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study.
    Colosimo C; Charles D; Misra VP; Maisonobe P; Om S;
    J Neurol Sci; 2020 Sep; 416():117015. PubMed ID: 32682125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study.
    Colosimo C; Charles D; Misra VP; Maisonobe P; Om S;
    J Neurol; 2019 Dec; 266(12):3038-3046. PubMed ID: 31501975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.